Latest Breaking News On - Equinox science - Page 2 : comparemela.com

EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team

EyePoint Pharmaceuticals Strengthens Board and Executive Leadership Team
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJays dukerChristina tartagliastern irdirectGeorge elstonBetta pharmaceuticalsGuggenheim securitiesOptherion incEyepoint pharmaceuticalsHarvard business schoolPiper jaffrayAlimera sciencesExchange commissionCompany compensation committeeHead of corporate developmentJuniper pharmaceuticals incHead of corporate development at enzyvant therapeutics

EyePoint Pharmaceuticals : EYPT Investor Presentation September 2023 -September 13, 2023 at 10:14 am EDT

Investor Presentation September 2023 Forward-Looking Statements Various statements made in this presentation.

Betta pharmaceuticalsExchange commissionForward looking statementsSecurities litigation reform actOcumension therapeuticsEquinox science

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments

EyePoint Pharmaceuticals, Inc : EyePoint Pharmaceuticals Reports Second Quarter 2023 Financial Results and Highlights Recent Corporate Developments
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Hong kongUnited statesCzech republicJays dukerJay dukerChristina tartagliaAmy phillipsMarcia sellos mouraAmerican society of retina specialistsProgram leadership onEyepoint pharmaceuticals incEyepoint pharmaceuticalsBetta pharmaceuticalsAlimera sciencesEuropean society of ophthalmology congressExchange commission

EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit

EyePoint Pharmaceuticals Presents Interim Masked Safety Data and Patient Baseline Characteristics for DAVIO 2 Clinical Trial at OIS Retina Innovation Summit
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesJays dukerChristina tartagliastern irdirectEyepoint pharmaceuticals incAlimera sciencesEquinox sciencesExchange commissionEyepoint pharmaceuticals nasdaqEyepoint pharmaceuticalsBetta pharmaceuticalsPoint pharmaceuticalsInnovation summitNancy lurkerExecutive vice chairChief executive officerPrivate securities litigation reform act

EyePoint Pharmaceuticals : EYPT Investor Presentation July 2023

Investor Presentation July 2023 Forward-Looking Statements Various statements made in this presentation are.

Exchange commissionBetta pharmaceuticalsForward looking statementsSecurities litigation reform actOcumension therapeuticsEquinox science